Timing of cesarean delivery for fetal heart rate abnormalities in hypertensive pregnancies induced with oral misoprostol or Foley catheter: Secondary analysis of a randomized clinical trial
International Journal of Gynecology & Obstetrics · 2024
DOI: 10.1002/ijgo.15375 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift International Journal of Gynecology & Obstetrics, 2024. Verfasst von Ambrogio P Londero und 4 weiteren Autor:innen. Beteiligte Einrichtung: Obstetrics and Gynecology Unit, IRCCS Istituto Giannina Gaslini, Genova, Italy. Hauptthemen laut MEDLINE: Misoprostol, Heart Rate, Fetal, Cesarean Section, Oxytocics. Die Arbeit nennt 24 Literaturangaben.
Abstract (Originalsprache)
Objective
The study aims to assess how oral misoprostol for cervical ripening affects the time of cesarean delivery (CD) for fetal heart rate (FHR) abnormalities in pre‐eclampsia patients. Secondary goals include determining the role of uterine hyperstimulation, comparing misoprostol with Foley catheter, and identifying risk factors for FHR abnormalities associated with CD.
Methods
A previously published randomized clinical trial was subjected to a secondary analysis (NCT01801410). We conducted a time‐dependent analysis, stratifying the population based on the final mode of induction used (low‐dose oral misoprostol vs Foley catheter).
Results
There was no CD for FHR abnormalities within 2 h of starting misoprostol. At 5 h, the cumulative incidence of CD for FHR abnormalities in the misoprostol group was 2.10%, while it was 1.00% in the Foley group ( P = 0.565). After 25 h, the CD risk for FHR abnormalities remained constant in both groups at 21.00% (95% confidence interval [CI] 15.00%–28.00%). Within 5 h of misoprostol induction, the risk of uterine hyperstimulation was similar in both groups (0.33% in misoprostol vs 0.34% in Foley group, P = 0.161). The risk of CD for FHR abnormalities was unaffected by newborn weight centiles.
Conclusion
There was no significant difference in CD risk for FHR abnormalities between misoprostol and Foley catheter induction. Nonetheless, the cumulative incidence of CD for FHR abnormalities increased faster in the misoprostol group, indicating that FHR monitoring timing should be tailored to the induction method.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Obstetrics and Gynecology Unit, IRCCS Istituto Giannina Gaslini, Genova, Italy.
- Department of Neurology, Rehabilitation, Ophthalmology, Genetics, Maternal and Infant Health (DiNOGMI), University of Genoa, Genoa, Italy.
- Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.
- Academic Unit of Obstetrics and Gynecology, IRCCS Ospedale San Martino, Genoa, Italy.
ORCID-Profile: Ambrogio P Londero, Anna Fichera, Rossana Orabona, Angelo Cagnacci, Federico Prefumo
Zitieren
APA
Londero, A. P., Fichera, A., Orabona, R., Cagnacci, A., & Prefumo, F. (2024). Timing of cesarean delivery for fetal heart rate abnormalities in hypertensive pregnancies induced with oral misoprostol or Foley catheter: Secondary analysis of a randomized clinical trial. International Journal of Gynecology & Obstetrics. https://doi.org/10.1002/ijgo.15375
Vancouver
Londero AP, Fichera A, Orabona R, Cagnacci A, Prefumo F. Timing of cesarean delivery for fetal heart rate abnormalities in hypertensive pregnancies induced with oral misoprostol or Foley catheter: Secondary analysis of a randomized clinical trial. International Journal of Gynecology & Obstetrics. 2024. doi:10.1002/ijgo.15375
BibTeX
@article{Londero2024,
author = {Londero, Ambrogio P and Fichera, Anna and Orabona, Rossana and Cagnacci, Angelo and Prefumo, Federico},
title = {Timing of cesarean delivery for fetal heart rate abnormalities in hypertensive pregnancies induced with oral misoprostol or Foley catheter: Secondary analysis of a randomized clinical trial},
journal = {International Journal of Gynecology & Obstetrics},
year = {2024},
doi = {10.1002/ijgo.15375}
}
EUVIMED